tiprankstipranks
Trending News
More News >
Santhera Pharmaceuticals Holding (CH:SANN)
:SANN

Compare Santhera Pharmaceuticals Holding (SANN) vs. Competitors

Compare
5 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Santhera Pharmaceuticals Holding
CHF12.60
CHF175.37M
-2.46
-23.17%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.42
CHF143.33M
-2.11
-26.05%
0 Buy
1 Hold
0 Sell
Hold
Basilea Pharmaceutica
CHF56.50
CHF667.52M
9.45
40.72%
2 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.62
CHF903.87M
-5.41
409.87%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF20.15
CHF400.29M
16.82
115.51%
2 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF21.30
CHF122.85M
3.82
0.00%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:SANN
Santhera Pharmaceuticals Holding
12.60
-4.26
-25.27%
CH:MOLN
Molecular Partners AG
3.42
-1.08
-23.92%
CH:BSLN
Basilea Pharmaceutica
56.50
15.85
38.99%
CH:IDIA
Idorsia Ltd
3.62
2.92
420.14%
CH:NWRN
Newron Pharmaceuticals SpA
20.15
10.40
106.67%
CH:XLS
Xlife Sciences Ltd.
20.60
-1.40
-6.36%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts